For professionals working with learning disabilities, there are many pieces of legislation, policy and practice to understand, and a wealth of guidance available to assist with this.
How should we think about post-pandemic grief support for people with a learning disability?
Mencap launches online TV channel amid increased reports of 'lockdown' loneliness
A round-up of changes that will impact learning disability and/or autism support during the Coronavirus pandemic
"We were already considered to be a family in crisis"
Lockdown on the spectrum: how autistic adults and families of children with the condition are coping with the coronavirus lockdown that has closed schools, slashed respite and limited access to the outdoors to one trip a day. Darren Devine highlights the experiences of one Scottish family facing struggles common to many during the lockdown.
Is school "refusal" really refusal? Navigating a system designed for neurotypical children
'Not Fine in School' is a parent-led organisation that supports, informs, and empowers parents affected by school non-attendance. On behalf of the organisation, Fran Morgan writes for Learning Disability Today about why the education system is failing to give all children the same support to thrive.
Should parents make care decisions once their child reaches adulthood?
Until a group of parents joined forces to change the law families could find themselves sidelined once a loved one with a learning disability turned eighteen, with social workers taking charge of key decisions. But here Darren Devine details how three families have fought to ensure parents continue to have a voice when their children become adults.
United Response adapts fire evacuation procedure to improve accessibility
School forced to reinstate and apologise for unlawful discrimination of disabled student
Have NHS efforts to reduce over medicating been successful?
In 2016, the UK government launched a groundbreaking drive to reduce the use of psychotropic drugs for people with autism and learning disabilities. But recent figures show that while prescribing rates for antipsychotics have fallen since the campaign’s launch, antidepressants, hypnotics, and stimulants have all risen.